We are live on ! Find out more
HAE icon

Haemonetics
HAE

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 328 → 324 (-4)

6.15% less ownership

Funds ownership: 108.62% → 102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M

Top Buyers

1
ICM
Invenomic Capital Management
Massachusetts
+$43.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$19.2M
3
Boston Partners
Boston Partners
Massachusetts
+$15.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$15.2M
5
RRAM
River Road Asset Management
Kentucky
+$14.7M

Top Sellers

1
Holocene Advisors
Holocene Advisors
New York
-$82M
2
Citadel Advisors
Citadel Advisors
Florida
-$67.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.9M
4
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss
Texas
-$41.9M
5
William Blair Investment Management
William Blair Investment Management
Illinois
-$25.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
51
Assenagon Asset Management
Luxembourg
$10M +$6.57M +100,910 +132%
Invesco
52
Invesco
Georgia
$9.99M +$550K +8,448 +5%
Jane Street
53
Jane Street
New York
$8.62M -$24.3M -373,329 -71%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$7.88M -$36.5K -561 -0.4%
Raymond James Financial
55
Raymond James Financial
Florida
$7.78M -$1.98M -30,345 -18%
UBS AM
56
UBS AM
Illinois
$7.65M +$269K +4,138 +3%
AllianceBernstein
57
AllianceBernstein
Tennessee
$7.38M +$30.3K +465 +0.5%
American Century Companies
58
American Century Companies
Missouri
$7.05M +$3.59M +55,192 +79%
JAM
59
Jupiter Asset Management
United Kingdom
$6.49M +$7.5M +115,094 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
60
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$6.44M +$7.44M +114,277 New
KIM
61
Kestrel Investment Management
California
$5.49M -$45.6K -700 -0.7%
Swiss National Bank
62
Swiss National Bank
Switzerland
$5.22M -$156K -2,400 -3%
First Trust Advisors
63
First Trust Advisors
Illinois
$5.09M +$5.88M +90,263 New
Nordea Investment Management
64
Nordea Investment Management
Sweden
$5.05M -$296K -4,546 -5%
XT
65
XTX Topco
Cayman Islands
$4.96M +$5M +76,738 +685%
HA
66
Heartland Advisors
Wisconsin
$4.79M +$651K +10,000 +13%
AG
67
Algert Global
California
$4.39M +$56.7K +870 +1%
Prudential Financial
68
Prudential Financial
New Jersey
$4.35M +$2.02M +31,080 +67%
SBH
69
Segall Bryant & Hamill
Illinois
$4.17M +$3.28M +50,412 +214%
RA
70
Royce & Associates
New York
$4.03M – – –
SCP
71
Seizert Capital Partners
Michigan
$3.87M +$4.48M +68,729 New
ACM
72
American Capital Management
New York
$3.77M -$488K -7,500 -10%
Walleye Capital
73
Walleye Capital
New York
$3.74M +$418K +6,411 +11%
SC
74
Skylands Capital
Wisconsin
$3.71M +$1.91M +29,350 +80%
BNP Paribas Asset Management
75
BNP Paribas Asset Management
France
$3.68M +$16K +245 +0.4%
1 2
3
4 5

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.